1. DNMT1 mediated promoter methylation of GNAO1 in hepatoma carcinoma cells
   Diannan Xu et al, 2018, Gene CrossRef
2. Expression levels of EPHB4, EFNB2 and caspase‑8 are associated with clinicopathological features and progression of esophageal squamous cell cancer
   Qianzhi Ni et al, 2019, Oncol Lett CrossRef
3. The Role of Apoptosis as a Double-Edge Sword in Cancer
   Reyhaneh Farghadani et al, 2021 CrossRef
4. Therapeutic potential of marine peptides in glioblastoma: Mechanistic insights
   Salman Ahmed et al, 2021, Cellular Signalling CrossRef
5. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
   Vesna Risso et al, 2022, Cell Death Dis CrossRef
6. Multidrug resistance, a major obstacle in hepatocellular carcinoma treatment: challenges and future perspectives
   Tarun Sahu et al, 2022 CrossRef
7. MLKL deficiency in BrafV600EPten−/− melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice
   Sofie Martens et al, 2022, Cell Death Dis CrossRef
8. Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis
   Chou-Yi Hsu et al, 2024, Front. Pharmacol. CrossRef
9. Recent Advances in Marine-Derived Nanoformulation for the Management of Glioblastoma
   Chanam Melody Devi et al, 2024, Mol Biotechnol CrossRef
10. Caspase-8 in inflammatory diseases: a potential therapeutic target
    Wangzheqi Zhang et al, 2024, Cell Mol Biol Lett CrossRef
11. Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression
    Ruimin He et al, 2024, Mol Cancer CrossRef